Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Press/Media
Student theses
Datasets
Search by expertise, name or affiliation
View Scopus Profile
Yuan MA, Dr
Research Assistant Professor
,
Chinese Medicine - Teaching and Research Division
https://orcid.org/0000-0002-7846-4863
Email
mayuan
hkbu.edu
hk
2014
2024
Research activity per year
Overview
Fingerprint
Network
Research Output
(32)
Prizes / Awards
(1)
Activities
(6)
Similar Scholars
(6)
Fingerprint
Dive into the research topics where Yuan MA is active. Topic labels come from the works of this scholar. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Aptamer
100%
Small Interfering RNA (siRNA)
75%
Lipids
31%
Cationic Lipids
28%
Sclerostin
28%
Binding Affinity
28%
Modification Strategies
24%
Triple-negative Breast Cancer
24%
HnRNPA1
21%
Nucleic Acids
19%
Modified Aptamers
19%
Nucleic Acid Drug
18%
Duplex
18%
Bone Anabolic Effects
17%
Hydrogen Bonds (H-bonds)
17%
Serum Stability
17%
High Affinity
16%
Affinity Enhancement
16%
Paclitaxel
16%
Antisense Oligonucleotides
15%
Oligonucleotides
14%
Gene Silencing
13%
Amphiphiles
12%
Cancer Cells
12%
In Vivo Efficacy
12%
Nucleic Acid Aptamer
11%
Nanomedicine
11%
Aptamer Targeting
10%
Structural Optimization
10%
Aptamer-based
9%
Pharmacokinetics
9%
Cleavage Site
9%
Pancreatic Cancer Treatment
9%
Chemotherapy
9%
Tumor Microenvironment
9%
Targeted Therapy
9%
Nuclease
9%
Peptide Conjugation
9%
Annealing
9%
AS1411
9%
Ago2
9%
Targeted Delivery
9%
Artificial Intelligence
9%
Chemical Modification
9%
Osteogenesis Imperfecta
8%
Drug-resistant Lung Cancer
8%
Stability Improvement
8%
Bone Loss
8%
Rare Bone Disease
8%
Therapeutic Perspectives
8%
Pharmacology, Toxicology and Pharmaceutical Science
Aptamer
95%
Neoplasm
34%
Nucleic Acid
32%
Sclerostin
30%
Malignant Neoplasm
30%
Small Interfering RNA
28%
Triple Negative Breast Cancer
20%
Chemotherapy
19%
Drug
19%
Heterogeneous Nuclear Ribonucleoprotein A1
16%
Pancreas Cancer
16%
Messenger RNA
16%
Antisense Oligonucleotide
15%
Oligonucleotide
15%
Paclitaxel
14%
Melanoma
10%
Pharmacokinetic
10%
Tumor Microenvironment
9%
Tumor Growth
8%
Lung Cancer
8%
Drug Discovery
8%
Nucleolin
8%
Oblimersen
8%
microRNA 122
8%
Doxifluridine
8%
Metastasis
8%
Lipoplex
8%
Controlled Drug Release
8%
Liver Cell Carcinoma
8%
Nucleic Acid Base
8%
Hypoxia Inducible Factor
8%
Polyethylene Glycol
8%
Target Identification
8%
Bone Disease
8%
Plasmid DNA
8%
Hypoxia
8%
Prodrug
8%
Osteogenesis Imperfecta
7%
Diseases
7%
Zeta Potential
6%
Gene Delivery
6%
Human Serum Albumin
6%
Ltvax
6%
Hydrogen Peroxide
5%
Carcinogenesis
5%
Fluorouracil
5%
Biochemistry, Genetics and Molecular Biology
Aptamer
77%
Small Interfering RNA
43%
Lipid
27%
Binding Affinity
25%
Oligonucleotide
25%
Antisense
22%
Ribonucleoprotein
20%
Cationic Lipid
19%
Sclerostin
18%
Nuclease
18%
Nucleic Acid
13%
Tumor Progression
12%
Cancer Cell
10%
Bone Development
10%
Messenger RNA
10%
Gene Inactivation
9%
Nucleobase
9%
RNA-induced Silencing Complex
9%
Conformation
8%
KRAS
8%
Small RNAs
8%
Promoter Region
8%
Pharmacokinetic
8%
Transfection
8%
Hypoxia-Inducible Factors
8%
Drug Resistance
8%
Plasmid
8%
Programmed Cell Death
7%
Locked Nucleic Acid
5%
